Common Factors Affecting Peptide Dosing Protocols When a clinician writes a peptide plan, they look at a lot of things: Patient goals and symptoms Medical and injury history Contraindications and current meds ADT: Previous exposure to peptides Method of administration Product concentration Time frame of treatment The monitoring plan Non-clinicians shouldn't make these choices, and don't just copy what other clinics do without review by your medical director
In these situations, patients may have high B12 on blood work but still exhibit neurological symptoms of deficiency (tingling, numbness, cognitive changes)
BPC-157 has also been associated with potential anti-inflammatory and gastroprotective properties , particularly in studies examining tissue protection and recovery mechanisms
We're 53 and 52 years old, and honestly, we feel like we're in our 30s again
Distillation removes minerals and contaminants, but it doesn't sterilize